During the past decade, Vimta Labs Ltd., conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Vimta Labs Ltd.," are "Healthy" (7 trials), "Fasting" (3 trials), "FED" (1 trials) and "Fed" (1 trials). Many other conditions were trialed in "Vimta Labs Ltd.," in a lesser frequency.

Most popular intervention types in "Vimta Labs Ltd.," are "Drug" (12 trials). Other intervention types were less common.

The name of intervention was led by "Amlodipine Besylate/Benazepril HCl" (2 trials), "Glucophage" (2 trials), "Levocetirizine DiHCl" (2 trials), "Metformin" (2 trials) and "Ondansetron Hydrochloride" (2 trials). Other intervention names were less common.

The vast majority of trials in "Vimta Labs Ltd.," are 8 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Vimta Labs Ltd.,". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Vimta Labs Ltd.,, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Vimta Labs Ltd.,, 12 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".